Abstract: Among other things, the present disclosure provides technologies for oligonucleotide preparation, particularly chirally controlled oligonucleotide preparation, which technologies provide greatly improved crude purity and yield, and significantly reduce manufacturing costs.
Description:AS ATTACHED , Claims:AS ATTACHED
| # | Name | Date |
|---|---|---|
| 1 | 202418015117-STATEMENT OF UNDERTAKING (FORM 3) [29-02-2024(online)].pdf | 2024-02-29 |
| 2 | 202418015117-Sequence Listing in txt [29-02-2024(online)].txt | 2024-02-29 |
| 3 | 202418015117-Sequence Listing in PDF [29-02-2024(online)].pdf | 2024-02-29 |
| 4 | 202418015117-REQUEST FOR EXAMINATION (FORM-18) [29-02-2024(online)].pdf | 2024-02-29 |
| 5 | 202418015117-POWER OF AUTHORITY [29-02-2024(online)].pdf | 2024-02-29 |
| 6 | 202418015117-FORM 18 [29-02-2024(online)].pdf | 2024-02-29 |
| 7 | 202418015117-FORM 1 [29-02-2024(online)].pdf | 2024-02-29 |
| 8 | 202418015117-DRAWINGS [29-02-2024(online)].pdf | 2024-02-29 |
| 9 | 202418015117-DECLARATION OF INVENTORSHIP (FORM 5) [29-02-2024(online)].pdf | 2024-02-29 |
| 10 | 202418015117-COMPLETE SPECIFICATION [29-02-2024(online)].pdf | 2024-02-29 |
| 11 | 202418015117-FORM 3 [27-08-2024(online)].pdf | 2024-08-27 |